Search results
Jump to navigation
Jump to search
Google site results
Loading...
Wiki results
- ...h an interest in clinical cytogenetics, molecular genetics and genomics in cancer. [[Contact us]] for more information.''' [[File:Circos.png|100px|link=Main_Page]] '''Cancer Genomes''' [[Hematologoic and Lymphoid]] | [[Solid Tumors]] | [[CNS]] | [[P7 KB (905 words) - 22:59, 20 November 2017
- == Genes == * Cancer Genes A10 KB (1,089 words) - 22:30, 20 November 2017
- [[Category:T-ALL]] ...Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13907 bytes (101 words) - 10:44, 26 August 2016
- [[Category:T-ALL]] ...Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13870 bytes (103 words) - 11:03, 26 August 2016
- [[Category:T-ALL]] ...Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13947 bytes (106 words) - 11:02, 26 August 2016
- [[File:t(1;8)(p13;q24.1).png|t(1;8)(p13;q24.1)]] ...Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13867 bytes (99 words) - 10:37, 26 August 2016
- [[File:t(1;19)(q23;p13.3).png|t(1;19)(q23;p13.3)]] ...Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13906 bytes (103 words) - 10:37, 26 August 2016
- [[File:t(1;3)(p36;q21).png|t(1;3)(p36;q21)]] ...Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13934 bytes (107 words) - 15:39, 19 August 2016
- ...h an interest in clinical cytogenetics, molecular genetics and genomics in cancer.''' ...ermission from the copyright holder, ©International Agency for Research on Cancer.''|alt=]]7 KB (1,032 words) - 10:43, 5 March 2024
- ...as been shown to mediate elevated expression of [[HOXA| ''HOXA'']] cluster genes [7]. [[T-ALL|T-cell Acute Lymphoblastic Leukemia/Lymphoma]]3 KB (479 words) - 14:09, 31 August 2016
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (552 words) - 16:13, 30 April 2019
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (579 words) - 18:16, 29 July 2018
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 12:25, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 12:24, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 12:23, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 12:13, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 12:06, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 12:02, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:59, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:58, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:57, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:46, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:45, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:44, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:43, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:42, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:42, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:41, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:40, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:35, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:39, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:35, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:34, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:34, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:32, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:31, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:29, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:28, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:27, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:25, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:24, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 11:26, 26 July 2017
- ==Cancer Category/Type== Breast cancer3 KB (455 words) - 16:00, 28 June 2017
- ==Cancer Category/Type== Breast Cancer3 KB (455 words) - 16:01, 28 June 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 18:06, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 18:06, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 18:05, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 18:05, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 18:03, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 18:01, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 18:00, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 17:59, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 17:59, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 17:58, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 17:58, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 17:56, 13 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 15:52, 28 June 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:14, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:14, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:14, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:13, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:13, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:13, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:13, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:12, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:12, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:12, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:11, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:11, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:10, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:10, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:11, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:10, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:09, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:08, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:09, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:09, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 16:08, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 13:18, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 13:17, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 13:13, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 13:12, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 13:06, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 13:08, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:59, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:57, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:56, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:55, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:51, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:49, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:45, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:44, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:41, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:40, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:39, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:38, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:36, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:35, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:33, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:32, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:22, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:06, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:07, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:10, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:10, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:12, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:12, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:20, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:21, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:02, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:01, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 12:00, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:59, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:59, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:58, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:57, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:52, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:50, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:51, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:49, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:48, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:47, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:46, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:45, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:44, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:43, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (457 words) - 11:42, 8 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 16:13, 23 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 12:21, 26 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 12:21, 26 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 12:16, 26 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 12:18, 26 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 12:02, 26 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 12:03, 26 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (454 words) - 12:01, 26 July 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (464 words) - 16:58, 16 April 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (464 words) - 19:51, 9 August 2017
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (465 words) - 12:41, 15 May 2018
- One of several t(11;17) events that appear identical down the microscope. The KMT2A-MLLT6 ch Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with het693 bytes (96 words) - 09:37, 10 March 2016
- ==General Disease Overview / Description of Cancer Category== ...loid leukemia (AML) are driven by genomic alterations such as mutations in genes encoding transcription factors (''GATA-2'', ''RUNX1'', ''ETV6'', and ''CEBP8 KB (1,042 words) - 14:40, 12 December 2023
- 2 General Disease Overview / Description of Cancer Category ...ary risk associations in breast cancer according to National Comprehensive Cancer Network (NCCN) Guidelines (version 3.2019)'''3 KB (377 words) - 16:45, 11 July 2019
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (450 words) - 10:55, 8 April 2020
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (576 words) - 20:25, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:30, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:37, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:29, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:27, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:25, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:26, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:26, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:26, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:27, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:24, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:25, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:24, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:22, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:22, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:38, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:38, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:38, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:37, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:37, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:30, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:18, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:17, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:18, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 18:16, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:28, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:28, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:28, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:27, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:27, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:23, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:24, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (587 words) - 20:22, 29 July 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==3 KB (480 words) - 08:41, 15 April 2021
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]5 KB (719 words) - 16:30, 16 June 2019
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]5 KB (719 words) - 16:28, 16 June 2019
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]5 KB (719 words) - 16:31, 16 June 2019
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]5 KB (719 words) - 16:31, 16 June 2019
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (591 words) - 18:24, 11 October 2020
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]5 KB (717 words) - 14:37, 10 August 2023
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (636 words) - 18:15, 29 July 2018
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]5 KB (697 words) - 13:18, 26 January 2020
- ==Cancer Category/Type== DEK is implicated in acute myeloid leukemia and is associated with t(6;9)(p23;q34.1) resulting in DEK-NUP214 fusion protein. The DEK protein bin4 KB (650 words) - 16:45, 19 February 2022
- ==Cancer Category/Type== ...yeloid clone by dissociating the PML/RAR-alpha-RXR complex from the target genes and was found to have a synergistic action with ATRA [4].8 KB (1,102 words) - 14:48, 12 December 2023
- ==Cancer Category/Type== ...on Database (LOVD(3)) 15) TICdb - database of Translocation breakpoints In Cancer 16) GeneReviews, and 17) Any gene-specific databases.5 KB (769 words) - 13:44, 12 December 2023
- ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]4 KB (583 words) - 15:24, 15 July 2018
- ==Cancer Category/Type== inv(16)(p13;q22) or t(16)(p13;q22), (CBFB andMYH11) also translocation confer a favorable progn6 KB (780 words) - 10:41, 2 August 2018
- ==Cancer Category/Type== ..._CBFB::MYH11_fusion Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]'''6 KB (910 words) - 14:36, 12 December 2023
- ...cancer working group|url=https://pubmed.ncbi.nlm.nih.gov/32087595|journal=Cancer Genetics|volume=244|pages=11–20|doi=10.1016/j.cancergen.2020.02.002|issn= Abbreviations: TNBC, triple negative breast cancer; LOH, loss of heterozygosity.6 KB (894 words) - 17:42, 22 April 2021
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==4 KB (553 words) - 10:02, 3 August 2017
- ==Cancer Category/Type== ...Medicine Knnowledgebase (Weill Cornell), 6) Cancer Index, 7) OncoKB, 8) My Cancer Genome, 9) UniProt, 10) Pfam, 11) GeneCards, 12) GeneReviews, and 13) Any g4 KB (615 words) - 14:31, 12 December 2023
- ==Cancer Category/Type== ...yeloid clone by dissociating the PML/RAR-alpha-RXR complex from the target genes and was found to have a synergistic action with ATRA [5].7 KB (998 words) - 14:45, 12 December 2023
- Translocation t(14;19)(q32;q13.3): IGH/BCL3 It should not be confused with the t(14;19) rearrangement found in B-ALL involving the same breakpoints but targ4 KB (537 words) - 21:44, 20 July 2016
- ==Cancer Category/Type== 6) Cancer Index,5 KB (717 words) - 11:50, 11 April 2019
- ==Cancer Category/Type== ...oid_leukaemia_with_RUNX1::RUNX1T1_fusion Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]'''7 KB (1,022 words) - 14:48, 12 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 13:34, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 13:50, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 13:50, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 13:48, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 15:04, 6 October 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 11:50, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 12:47, 3 October 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 12:48, 3 October 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 11:47, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 13:54, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 13:54, 25 February 2024
- ==Cancer Category/Type== ...lia, but also as AML and they may even present as, or evolve to, precursor T or B lymphoblastic leukaemia/lymphoma with prominent eosinphils." (p.28).10 KB (1,469 words) - 17:05, 11 October 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (887 words) - 13:51, 25 February 2024
- ==Cancer Category/Type== ..., hematopoietic and lymphoid cancers (13.8%), and Melanomas (7%) ([https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=kit see COSMIC]).7 KB (1,047 words) - 14:32, 12 December 2023
- ==Cancer Category/Type== ...AAT/enhancer-binding proteins beta and gamma to modulate the expression of genes involved in cell cycle regulation. It coordinates proliferation arrest and7 KB (1,051 words) - 13:53, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,368 words) - 15:12, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,391 words) - 18:27, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,389 words) - 18:22, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,392 words) - 18:23, 23 December 2023
- ==Cancer Category/Type== ...urr. Biol. 9: 1373-1381, 1999.</ref><ref>Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adapto5 KB (787 words) - 14:00, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,434 words) - 10:50, 27 February 2024
- ...riginal page can be found at [[HAEM4:Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]]. ==Cancer Category / Type==10 KB (1,386 words) - 14:35, 13 December 2023
- {{DISPLAYTITLE:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes}} ==Cancer Category / Type==11 KB (1,530 words) - 14:34, 13 December 2023
- ...e 4th edition was Fibrin-Associated Diffuse Large B-cell Lymphoma and didn't have content. ==Cancer Category / Type==10 KB (1,435 words) - 11:55, 23 December 2023
- [[Category:Somatically Mutated Genes]] ...na, MD, M.D. Anderson Cancer Center and Min Fang, MD, PhD, Fred Hutchinson Cancer Research Center8 KB (1,195 words) - 21:24, 6 August 2016
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:37, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:38, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:43, 25 February 2024
- ==Cancer Category/Type== ...oid_leukaemia_with_RUNX1::RUNX1T1_fusion Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]'''11 KB (1,545 words) - 14:48, 12 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3]]. ==Cancer Category / Type==10 KB (1,436 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:31, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 10:47, 29 January 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:39, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:41, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:42, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,494 words) - 16:44, 4 March 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,460 words) - 13:26, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,501 words) - 18:38, 27 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==9 KB (1,266 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,506 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:41, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:38, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:28, 13 December 2023
- {{DISPLAYTITLE:Subcutaneous panniculitis-like T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,515 words) - 14:40, 13 December 2023
- {{DISPLAYTITLE:Indolent T-lymphoblastic proliferation}} ==Cancer Category / Type==11 KB (1,512 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:24, 13 December 2023
- {{DISPLAYTITLE:Extranodal NK/T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,515 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:27, 13 December 2023
- {{DISPLAYTITLE:Peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,515 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,520 words) - 11:21, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:39, 13 December 2023
- {{DISPLAYTITLE:T-lymphoblastic leukaemia / lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,517 words) - 15:33, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 15:52, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:35, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,517 words) - 15:33, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,533 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:34, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,521 words) - 14:38, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous gamma/delta T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,521 words) - 14:38, 13 December 2023
- {{DISPLAYTITLE:T-cell/histiocyte-rich large B-cell lymphoma}} ==Cancer Category / Type==11 KB (1,518 words) - 14:41, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,529 words) - 15:31, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==13 KB (1,759 words) - 14:19, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder}} ==Cancer Category / Type==11 KB (1,527 words) - 14:38, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:38, 13 December 2023
- ...AYTITLE:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,530 words) - 14:37, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis}} ==Cancer Category / Type==11 KB (1,530 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,536 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,539 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,545 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,556 words) - 14:28, 13 December 2023
- ==Cancer Category/Type== ...substitution mutations, is found at a low level in many cancers ([https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=etv6 see COSMIC]); it is more prominen9 KB (1,371 words) - 14:18, 12 December 2023
- ==Cancer Category/Type== ...ith Chronic Myeloid Leukemia have a Philadelphia chromosome resulting from t(9;22)(q34.1;q11.2), which is a reciprocal translocation between chromosome12 KB (1,749 words) - 13:50, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,601 words) - 15:20, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,576 words) - 14:40, 6 March 2024
- {{DISPLAYTITLE:Intestinal T-cell lymphoma, NOS}} ...mplate on 2023-12-07. The original page can be found at [[HAEM4:Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]].13 KB (1,756 words) - 14:28, 13 December 2023
- '''Cancer Category/Type''' '''Cancer Sub-Classification/Subtype'''7 KB (872 words) - 15:02, 12 December 2023
- ==Cancer Category/Type== Nearly universal involvement in diverse cancer types.11 KB (1,625 words) - 18:14, 5 January 2019
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (2,002 words) - 14:18, 13 December 2023
- Hui Chen, MD, PhD, The University of Texas MD Anderson Cancer Center ==Cancer Category/Type==9 KB (1,336 words) - 16:42, 16 April 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,992 words) - 14:26, 13 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1]]. Cancer Category/Type14 KB (1,917 words) - 14:20, 13 December 2023
- [[File:T(6;9)(p23;q34).png]] ==Cancer Category/Type==10 KB (1,452 words) - 10:55, 12 September 2022
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,064 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,127 words) - 14:23, 13 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged]]. ==Cancer Category / Type==12 KB (1,796 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,146 words) - 12:07, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==16 KB (2,256 words) - 14:31, 13 December 2023
- ...ssue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). <nowiki>htt !Chromosomal Rearrangement!!Genes in Fusion (5’ or 3’ Segments)!!Pathogenic Derivative!!Prevalence13 KB (1,889 words) - 14:19, 14 March 2024
- Thank you for volunteering to help curate the Compendium of Cancer Genome Aberrations (CCGA)! Your help will make this resource a valuable to .... The CCGA is interested in the curation of genes/mutations that arise in cancer. However, the dividing line between "Gene/Protein/Mutation" information an23 KB (3,717 words) - 14:25, 12 December 2023
- T. Niroshi Senaratne, UCLA ==Cancer Category / Type==16 KB (2,266 words) - 14:39, 13 December 2023
- ==Cancer Category/Type== ...ith Chronic Myeloid Leukemia have a Philadelphia chromosome resulting from t(9;22)(q34.1;q11.2), which is a reciprocal translocation between chromosome12 KB (1,695 words) - 13:43, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,323 words) - 14:34, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==18 KB (2,507 words) - 15:34, 20 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1]]. ==Cancer Category / Type==15 KB (2,139 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,944 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,084 words) - 14:18, 13 December 2023
- ...>Diaz JI, Mora LB, Hakam A. The Mainz Classification of Renal Cell Tumors. Cancer Control. 1999 Nov;6(6):571-579</ref> ...ton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 8;26(3):319-30.</ref>3 KB (421 words) - 11:29, 22 August 2016
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,329 words) - 15:49, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,153 words) - 14:35, 13 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1]]. ==Cancer Category / Type==17 KB (2,425 words) - 14:21, 13 December 2023
- ...stic large cell lymphoma”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated 12/13/2023, <nowiki>https://ccga.io/inde ...ccur.<ref>Karikari, I.O.; Thomas, K.K.; Lagoo, A.; Cummings, T.J.; George, T.M. Primary Cerebral ALK-1-Positive Anaplastic Large Cell Lymphoma in a Chil10 KB (1,484 words) - 22:04, 27 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,020 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== Mature T-cell neoplasm / Cutaneous T-cell lymphoma19 KB (2,695 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,883 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,607 words) - 14:29, 13 December 2023
- ==Cancer Category/Type== Non-small cell lung cancer (NSCLC)12 KB (1,650 words) - 14:21, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==16 KB (2,259 words) - 14:18, 13 December 2023
- {{DISPLAYTITLE:Hepatosplenic T-cell lymphoma}} ...ate on 2023-12-07. The original page can be found at [[HAEM4:Hepatosplenic T-cell Lymphoma]].22 KB (3,064 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,355 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== Breast cancer / Fibroepithelial Tumors of the Breast16 KB (2,255 words) - 13:27, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,944 words) - 14:27, 13 December 2023
- ==Cancer Category/Type== Colorectal cancer13 KB (1,790 words) - 18:29, 5 January 2019
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==16 KB (2,262 words) - 14:40, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==14 KB (2,044 words) - 10:09, 27 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==14 KB (1,866 words) - 11:58, 13 April 2020
- ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214]]. [[File:T(6;9)(p23;q34).png]]19 KB (2,611 words) - 14:17, 13 December 2023
- ...al page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]]. ==Cancer Category / Type==19 KB (2,659 words) - 14:32, 13 December 2023
- ...can be found at [[HAEM4:Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]]. ==Cancer Category / Type==18 KB (2,546 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (1,965 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,652 words) - 14:34, 13 December 2023
- ...liferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]]. ==Cancer Category / Type==18 KB (2,549 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,372 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,651 words) - 14:36, 13 December 2023
- {{DISPLAYTITLE:Indolent T-cell lymphoma of the gastrointestinal tract}} ...template on 2023-12-07. The original page can be found at [[HAEM4:Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]].20 KB (2,747 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,651 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,307 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== * [[HAEM4:Mature T- and NK-cell Neoplasms]]19 KB (2,622 words) - 14:21, 13 December 2023
- {{DISPLAYTITLE:Monomorphic epitheliotropic intestinal T-cell lymphoma}} ...iginal page can be found at [[HAEM4:Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]].19 KB (2,721 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==20 KB (2,830 words) - 14:34, 13 December 2023
- ==Cancer Category/Type== *T-cell acute lymphoblastic leukaemia (T-ALL)14 KB (1,939 words) - 18:10, 5 January 2019
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,015 words) - 14:30, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==17 KB (2,350 words) - 13:52, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,722 words) - 14:16, 13 December 2023
- ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]]. ==Cancer Category / Type==21 KB (2,953 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,067 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,639 words) - 14:38, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (2,984 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==25 KB (3,405 words) - 14:26, 13 December 2023
- {{DISPLAYTITLE:Mixed-phenotype acute leukaemia, T/myeloid}} ...iginal page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]].19 KB (2,751 words) - 14:31, 13 December 2023
- UT MD Anderson Cancer Center ==Cancer Category / Type==21 KB (2,945 words) - 14:37, 13 December 2023
- ...al page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]]. ==Cancer Category / Type==21 KB (2,942 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,703 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,920 words) - 14:35, 13 December 2023
- ...able derived from Akkari et al., 2020 [PMID 32302940] with permission from Cancer Genetics. All percentages are approximate. |t(12;21)(p13;q22); [[ETV6]]-[[RUNX1]]*33 KB (4,848 words) - 10:50, 26 July 2021
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,114 words) - 14:16, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell ==Cancer Category / Type==23 KB (3,154 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==24 KB (3,252 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,077 words) - 14:26, 13 December 2023
- ==Cancer Category/Type== * Angioimmunoblastic T-cell lymphoma20 KB (2,671 words) - 14:44, 10 August 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==19 KB (2,643 words) - 13:51, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,981 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==20 KB (2,857 words) - 14:35, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,638 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== Mature T- and NK-cell neoplasms21 KB (2,919 words) - 14:19, 13 December 2023
- {{DISPLAYTITLE:T-large granular lymphocytic leukaemia}} ...the new template on 2023-12-07. The original page can be found at [[HAEM4:T-cell Large Granular Lymphocytic Leukemia]].22 KB (3,037 words) - 14:41, 13 December 2023
- ==Cancer Category/Type== ...scular endothelial growth factor (''VEGF'') (Merdzhanova et al., 2010). In cancer, ''SRSF2'' variants have been implicated in leukemia and myeloid disorders16 KB (2,281 words) - 14:50, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,152 words) - 14:16, 13 December 2023
- .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)23 KB (3,285 words) - 15:49, 13 September 2019
- .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)23 KB (3,285 words) - 16:56, 8 August 2020
- .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)23 KB (3,282 words) - 11:49, 14 June 2019
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,890 words) - 14:33, 13 December 2023
- ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]]. ==Cancer Category / Type==29 KB (4,172 words) - 14:17, 13 December 2023
- ==Cancer Category/Type== Breast Cancer / Epithelial Tumours of the Breast19 KB (2,737 words) - 13:17, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,639 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,967 words) - 14:22, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,936 words) - 14:33, 13 December 2023
- ...e found at [[HAEM4:Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]]. [[File:t(3;3)(q21;q26.2).png|t(3;3)(q21;q26.2)]]25 KB (3,672 words) - 14:17, 13 December 2023
- Victorian Cancer Cytogenetics Service ==Cancer Category / Type==28 KB (3,984 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,785 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==24 KB (3,323 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,643 words) - 14:36, 13 December 2023
- ==Cancer Category/Type== ...ET2 and WT1 physically interact, suggesting overlapping pathways for these genes in AML (Wang et al., 2015). ''TET2'' mutations increase the response of low26 KB (3,824 words) - 15:01, 12 December 2023
- {{DISPLAYTITLE:Adult T-cell leukaemia/lymphoma}} ...ew template on 2023-12-07. The original page can be found at [[HAEM4:Adult T-cell Leukemia/Lymphoma]].30 KB (4,300 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,527 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==24 KB (3,361 words) - 14:22, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==24 KB (3,361 words) - 14:22, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==30 KB (4,118 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,680 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==28 KB (3,914 words) - 14:36, 13 December 2023
- ...ed from Kanagal-Shawanna et al., 2018 [PMID 30377088] with permission from Cancer Genetics. ...urvival in a cohort of MDS or AML patients treated with azacitidine. Blood Cancer J 2013;3:e155.[https://www.ncbi.nlm.nih.gov/pubmed/24185502]</ref><ref name38 KB (5,270 words) - 17:10, 30 April 2020
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==29 KB (4,102 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,074 words) - 13:28, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==32 KB (4,341 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==40 KB (5,552 words) - 14:34, 13 December 2023
- ==Cancer Category/Type== ===Role in Cancer===20 KB (2,904 words) - 03:02, 13 August 2018
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,703 words) - 14:23, 13 December 2023
- Cancer Metastasis Rev (2014) 33:1109–1124 PMID:[http://www.ncbi.nlm.nih.gov/pubm ...gnature PI3K/AKT and mTOR pathways elevated; high expression of several genes representing targets for immunotherapy including PDCD1, CD247, PDCD1LG2, CT8 KB (1,050 words) - 16:48, 19 August 2016
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,637 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==25 KB (3,458 words) - 14:35, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,137 words) - 10:13, 27 February 2024
- !Chromosomal Rearrangement!!Genes in Fusion (5’ or 3’ Segments)!!Pathogenic Derivative!!Prevalence ...linelibrary.wiley.com/doi/10.1002/gcc.22083|journal=Genes, Chromosomes and Cancer|language=en|volume=52|issue=10|pages=873–886|doi=10.1002/gcc.22083|issn=121 KB (3,051 words) - 07:55, 22 April 2024
- ...Table derived from Pugh et al., 2018 [PMID 30393007] with permission from Cancer Genetics. |'''Genes'''17 KB (2,298 words) - 16:42, 22 April 2021
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,699 words) - 14:26, 13 December 2023
- {{DISPLAYTITLE:Systemic EBV-positive T-cell lymphoma of childhood}} ...023-12-07. The original page can be found at [[HAEM4:Systemic EBV-Positive T-cell Lymphoma of Childhood]].26 KB (3,630 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]32 KB (4,584 words) - 14:16, 13 December 2023
- {{DISPLAYTITLE:Enteropathy-associated T-cell lymphoma}} ...23-12-07. The original page can be found at [[HAEM4:Enteropathy-Associated T-cell Lymphoma]].31 KB (4,371 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==29 KB (4,258 words) - 14:22, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==21 KB (2,978 words) - 13:33, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==29 KB (3,951 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==34 KB (4,742 words) - 14:34, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,828 words) - 14:18, 13 December 2023
- ...n 2023-12-07. The original page can be found at [[HAEM4:Angioimmunoblastic T-cell Lymphoma]]. ==Cancer Category / Type==34 KB (4,909 words) - 14:35, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==34 KB (4,782 words) - 16:37, 20 December 2023
- ==Cancer Category/Type== [[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]22 KB (3,117 words) - 15:04, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,735 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==31 KB (4,299 words) - 14:17, 13 December 2023
- ==Cancer Category/Type== [[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]24 KB (3,522 words) - 15:04, 12 December 2023
- ...be found at [[HAEM4:Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]]. ==Cancer Category / Type==30 KB (4,324 words) - 14:16, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==23 KB (3,102 words) - 13:55, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==28 KB (3,970 words) - 14:19, 13 December 2023
- {{DISPLAYTITLE:Early T-precursor lymphoblastic leukaemia / lymphoma}} ...ew template on 2023-12-07. The original page can be found at [[HAEM4:Early T-Cell Precursor Lymphoblastic Leukemia]].25 KB (3,503 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==33 KB (4,726 words) - 14:22, 13 December 2023
- ...somal abnormalities identified by standard methods has led to discovery of genes, and gene function and dysfunction. This knowledge has led to improved ther ..., et al.; Adult Leukaemia Working Party, Medical Research Council/National Cancer Research Institute. Karyotype is an independent prognostic factor in adult59 KB (8,449 words) - 19:11, 27 July 2016
- ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]42 KB (5,916 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==40 KB (5,683 words) - 14:36, 13 December 2023
- ==Cancer Category/Type== * Prostate cancer38 KB (5,062 words) - 12:33, 10 August 2018
- ...Table derived from Chun et al., 2018 [PMID 30554732] with permission from Cancer Genetics. |'''Relevant Genes'''40 KB (5,707 words) - 22:25, 7 November 2020
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==34 KB (4,834 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==31 KB (4,295 words) - 14:22, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==39 KB (5,484 words) - 14:43, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==48 KB (6,794 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==56 KB (7,988 words) - 14:24, 13 December 2023
- The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas ==Cancer Category / Type==41 KB (5,923 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==42 KB (6,120 words) - 14:27, 13 December 2023
- ==Cancer Category/Type== '''Natural Killer/T-cell Lymphoma'''36 KB (5,335 words) - 14:18, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==55 KB (7,745 words) - 14:29, 13 December 2023
- ..., MS, Neuropathology Fellow Houston Methodist/Texas Children’s/MD Anderson Cancer Center ==Cancer Category/Type==36 KB (5,058 words) - 13:49, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==52 KB (7,572 words) - 14:28, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==31 KB (4,325 words) - 13:55, 25 February 2024
- ::T-cell and NK/T-cell lymphomas ::Mismatch repair cancer syndrome38 KB (3,868 words) - 13:56, 12 December 2023
- ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]64 KB (9,095 words) - 14:16, 13 December 2023
- ...Table derived from Liu et al., 2020 [PMID 32434132] with permission from Cancer Genetics. ...ehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer|url=https://pubmed.ncbi.nlm.nih.gov/23083876|journal=The Journal of Urology42 KB (5,820 words) - 13:40, 19 May 2021
- |Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center |T. Niroshi Senaratne, UCLA61 KB (7,864 words) - 16:23, 16 April 2024
- ...ist is based on the 2016 [http://cancer.sanger.ac.uk/census/ Sanger Centre Cancer Gene Census]. | [[ABL1]] || 9q34.1 || [[CML]],[[ALL]],[[T-ALL]] || [[BCR]],[[ETV6]],[[NUP214]]38 KB (4,038 words) - 18:34, 17 July 2016
- The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas ==Cancer Category / Type==80 KB (11,414 words) - 14:36, 13 December 2023
- ...://pubmed.ncbi.nlm.nih.gov/32203924/ PMID: 32203924]] with permission from Cancer Genetics. ...ilocytic astrocytomas|url=https://pubmed.ncbi.nlm.nih.gov/18974108|journal=Cancer Research|volume=68|issue=21|pages=8673–8677|doi=10.1158/0008-5472.CAN-08-103 KB (13,991 words) - 17:05, 20 April 2021